AAAAAA
Results:
1-23
|
Results: 23
Authors:
DIDIER A
LOOR F
Citation: A. Didier et F. Loor, THE ABAMECTIN DERIVATIVE IVERMECTIN IS A POTENT P-GLYCOPROTEIN INHIBITOR, Anti-cancer drugs, 7(7), 1996, pp. 745-751
Authors:
TIBERGHIEN F
LOOR F
Citation: F. Tiberghien et F. Loor, RANKING OF P-GLYCOPROTEIN SUBSTRATES AND INHIBITORS BY A CALCEIN-AM FLUOROMETRY SCREENING ASSAY, Anti-cancer drugs, 7(5), 1996, pp. 568-578
Authors:
DIDIER A
TIBERGHIEN F
WENGER R
LOOR F
Citation: A. Didier et al., DETECTION OF P-GLYCOPROTEIN EXPRESSION BY TUMORAL CELLS WITH NBDL-CSA, A FLUORESCENT DERIVATIVE OF CYCLOSPORINE-A, Anti-cancer drugs, 7(3), 1996, pp. 257-265
Authors:
DIDIER A
WENGER J
LOOR F
Citation: A. Didier et al., DECREASED UPTAKE OF CYCLOSPORINE-A BY P-GLYCOPROTEIN (PGP) EXPRESSINGCEM LEUKEMIC-CELLS AND RESTORATION OF NORMAL RETENTION BY PGP BLOCKERS, Anti-cancer drugs, 6(5), 1995, pp. 669-680
Authors:
ROSENBLATT N
HARTMANN KU
LOOR F
Citation: N. Rosenblatt et al., INTERACTIONS OF B6 WILD AND B6 GLD CELLS ENGRAFTED WITHIN ATHYMIC NUDE BEIGE RECIPIENTS, Autoimmunity, 20(1), 1995, pp. 9-18
Authors:
VELIN D
KUNTZ L
LOOR F
Citation: D. Velin et al., SEROLOGICAL ABNORMALITIES INDUCED BY ENGRAFTMENT OF VIABLE MOTH-EATENHEMATOPOIETIC-CELLS IN NUDE BEIGE RECIPIENTS, Autoimmunity, 20(1), 1995, pp. 25-32
Authors:
POURTIERMANZANEDO A
DIDIER A
FROIDEVAUX S
LOOR F
Citation: A. Pourtiermanzanedo et al., LYMPHOTOXICITY AND MYELOTOXICITY OF DOXORUBICIN AND SDZ PSC-833 COMBINED CHEMOTHERAPIES FOR NORMAL MICE, Toxicology, 99(3), 1995, pp. 207-217
Authors:
DIDIER AD
LOOR F
Citation: Ad. Didier et F. Loor, DECREASED BIOTOLERABILITY FOR IVERMECTIN AND CYCLOSPORINE-A IN MICE EXPOSED TO POTENT P-GLYCOPROTEIN INHIBITORS, International journal of cancer, 63(2), 1995, pp. 263-267
Authors:
ROSENBLATT N
HARTMANN KU
LOOR F
Citation: N. Rosenblatt et al., DEVELOPMENT OF GRAFTED GLD CELLS IN ATHYMIC AND EUTHYMIC RECIPIENTS, Immunology, 84(4), 1995, pp. 562-570
Authors:
JACHEZ B
CIANFRIGLIA M
LOOR F
Citation: B. Jachez et al., MODULATION OF HUMAN P-GLYCOPROTEIN EPITOPE EXPRESSION BY TEMPERATURE AND OR RESISTANCE-MODULATING AGENTS/, Anti-cancer drugs, 5(6), 1994, pp. 655-665
Authors:
JACHEZ B
BOESCH D
EMMER G
LOOR F
Citation: B. Jachez et al., SDZ 280-125 - A CYCLOPEPTOLIDE ENDOWED WITH AN IN-VITRO CYCLOSPORINE A-LIKE PROFILE OF ACTIVITY FOR THE REVERSION OF THE P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE OF TUMOR-CELLS, Anti-cancer drugs, 5(3), 1994, pp. 313-320
Authors:
BOESCH D
LOOR F
Citation: D. Boesch et F. Loor, EXTENT AND PERSISTENCE OF P-GLYCOPROTEIN INHIBITION IN MULTIDRUG-RESISTANT P388 CELLS AFTER EXPOSURE TO RESISTANCE-MODIFYING AGENTS, Anti-cancer drugs, 5(2), 1994, pp. 229-238
Authors:
EMMER G
GRASSBERGER MA
SCHULZ G
BOESCH D
GAVERIAUX C
LOOR F
Citation: G. Emmer et al., DERIVATIVES OF A NOVEL CYCLOPEPTOLIDE .2. SYNTHESIS, ACTIVITY AGAINSTMULTIDRUG-RESISTANCE IN CHO AND KB CELLS IN-VITRO, AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Journal of medicinal chemistry, 37(13), 1994, pp. 1918-1928
Authors:
FROIDEVAUX S
LOOR F
Citation: S. Froidevaux et F. Loor, MYELOID AND LYMPHOID-CELL ALTERATIONS IN NORMAL MICE EXPOSED TO CHEMOTHERAPY WITH DOXORUBICIN AND OR THE MULTIDRUG-RESISTANCE REVERSING AGENT SDZ-PSC-833/, International journal of cancer, 59(1), 1994, pp. 133-140
Authors:
TIBERGHIEN F
CEREDIG R
LOOR F
Citation: F. Tiberghien et al., INFLUENCE OF THE LPR ENVIRONMENT ON THE LYMPH-NODE CELL PHENOTYPES INC57BL 6 NUBG AND NULPR CHIMERAS/, Immunology, 83(4), 1994, pp. 552-561
Authors:
ROSENBLATT N
HARTMANN KU
LOOR F
Citation: N. Rosenblatt et al., THE YAA GENE-DEPENDENT B-CELL DEFICIENCY WORSENS THE GENERALIZED LYMPHADENOPATHY AND AUTOIMMUNITY OF C57BL 6-GLD MALE-MICE/, Immunology, 83(3), 1994, pp. 476-483
Authors:
ROSENBLATT N
HARTMANN KU
LOOR F
Citation: N. Rosenblatt et al., THE YAA MUTATION INDUCES THE DEVELOPMENT OF AUTOIMMUNITY IN MICE HETEROZYGOUS FOR THE GLD (GENERALIZED-LYMPHADENOPATHY-DISEASE) MUTATION, Cellular immunology, 156(2), 1994, pp. 519-528
Authors:
JACHEZ B
LOOR F
Citation: B. Jachez et F. Loor, ATYPICAL MULTIDRUG-RESISTANCE (MDR) - LOW-SENSITIVITY OF A P-GLYCOPROTEIN-EXPRESSING HUMAN-T LYMPHOBLASTOID MDR CELL-LINE TO CLASSICAL P-GLYCOPROTEIN-DIRECTED RESISTANCE-MODULATING AGENTS, Anti-cancer drugs, 4(6), 1993, pp. 605-615
Authors:
JACHEZ B
BOESCH D
GRASBERGER MA
LOOR F
Citation: B. Jachez et al., REVERSION OF THE P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE OF CANCER-CELLS BY FK-506 DERIVATIVES (VOL 4, PG 223, 1993), Anti-cancer drugs, 4(5), 1993, pp. 593-593
Authors:
JACHEZ B
BOESCH D
GRASSBERGER MA
LOOR F
Citation: B. Jachez et al., REVERSION OF THE P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE OF CANCER-CELLS BY FK-506 DERIVATIVES, Anti-cancer drugs, 4(2), 1993, pp. 223-229
Authors:
TIBERGHIEN F
PELUMIO F
KUNTZ L
LOOR F
Citation: F. Tiberghien et al., LACK OF TRANSFER OF LPR-TYPE ABNORMALITIES (LYMPHOPROLIFERATION OR LYMPHOID APLASIA) IN DOUBLE CONGENIC NUDE-BEIGE MICE ENGRAFTED WITH LPR HEMATOPOIETIC-CELLS, Immunology, 79(1), 1993, pp. 158-166
Authors:
VELIN D
GOETTELFINGER P
FROIDEVAUX S
LOOR F
Citation: D. Velin et al., GLD AND LPR HEMATOPOIETIC-CELL TRANSFERS - COMMON AND DIFFERENT SEROLOGICAL FEATURES OF THE C57BL 6 CHIMERAS/, Cellular immunology, 148(2), 1993, pp. 331-345
Authors:
POURTIERMANZANEDO A
DIDIER A
LOOR F
Citation: A. Pourtiermanzanedo et al., EXPRESSION OF P-GLYCOPROTEIN ON NORMAL LYMPHOCYTES - ENHANCEMENT OF THE DOXORUBICIN-SENSITIVITY OF CONCANAVALIN-A-RESPONDING MOUSE SPLEEN-CELLS BY P-GLYCOPROTEIN BLOCKERS, Oncology research, 4(11-12), 1992, pp. 473-480
Risultati:
1-23
|